Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes. - Bourlon C; Roddie C; Menne T; Norman J; O'Reilly M; Gibb A; Besley C; Chaganti S; Arias CG; Jones C; Dikair A; Allen S; et al. (Haematologica, 2024)